Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Effect of beta-glucan supplementation on cystic fibrosis colonic microbiota: an in vitro study

  • Asensio-Grau, Andrea
  • Cabrera-Rubio, Raúl
  • Masip, Etna
  • Ribes-Koninckx, Carmen
  • Collado, Maria Carmen
  • Calvo-Lerma, Joaquim
  • Heredia Gutiérrez, Ana Belén|||0000-0001-6629-9779
  • García Hernández, Jorge|||0000-0003-1258-6128
  • Andrés Grau, Ana María|||0000-0002-6132-3167
[EN] Children with cystic fibrosis (CF) present with gut dysbiosis, and current evidence impedes robust recommendations on the use of prebiotics. This study aimed at establishing the prebiotic potential of a commercial beta-glucan on the in vitro colonic microbiota of a child with CF compared to a healthy counterpart (H). A dynamic simulator of colonic fermentation (twin-SHIME® model) was set up including the simulation of the proximal (PC) and distal colon (DC) of the CF and the H subjects by colonizing the bioreactors with faecal microbiota. During two weeks the system was supplied with the beta-glucan. At baseline, during treatment and post-treatment, microbiota composition was profiled by 16 S rRNA and short-chain fatty acids (SCFA) production was determined by GS-MS. At baseline, Faecalibacterium, was higher in CF¿ DC than in the H, along higher Acidaminococcus and less Megasphaera and Sutterella. Beta-glucan supplementation induced increased microbiota richness and diversity in both subjects during the treatment. At genus level, Pseudomonas and Veillonella decreased, while Akkermansia and Faecalibacterium increased significantly in CF. The supplementation with beta-glucan suggests positive results on CF colonic microbiota in the in vitro context, encouraging further research in the in vivo setting., We thank the children and their families who were involved in the study and Veronica Ballester, the nurse of the paediatric CF unit of Hospital La Fe. RCB would like to acknowledge the support from Generalitat-Valenciana for the grant Plan GenT project (CDEIGENT 2020). JCL acknowledge the Juan de la Cierva Formación Postdoctoral contract awarded by the Spanish Ministry of Science and Innovation (FJC2019-041730-I). AAG would like also to thank the Post-doctoral contract awarded by the Universitat Politècnica de València (PAID-01-21). IATA-CSIC is a Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI / 10.13039/ 501100011033). This project was funded by Programa INBIO 2021 with reference PEDIMIC/AP2021-22 and Ayuda para potenciar la investigación postdoctoral de la UPV with reference PAIDPD-22.